Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast Cancer
PHASE4CompletedINTERVENTIONAL
Enrollment
104
Participants
Timeline
Start Date
August 1, 2019
Primary Completion Date
January 18, 2020
Study Completion Date
January 31, 2020
Conditions
Breast CancerNeutropenia
Interventions
DRUG
PEG-rhG-CSF
4.5mg per cycle, 24 hours after chemotherapy
Trial Locations (1)
100142
Beijing Cancer Hospital, Beijing
All Listed Sponsors
lead
Peking University
OTHER
NCT04009941 - Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast Cancer | Biotech Hunter | Biotech Hunter